Scholarlink

<p>Purpose: This network meta-analysis aimed to evaluate the comparative effect of five different protocols of IPL treatment in treating MGD-related DED, including optimal pulse technology [OPT]-based IPL, E &gt; eye-based IPL, OPT-based IPL plus meibomian gland expression (MGX), E &gt; eye-based IPL plus MGX, Eyesis-based IPL plus MGX. Methods: PubMed, Embase, Cochrane Library, SCOPUS and China National Knowledge Infrastructure (CNKI) were searched for eligible studies published before November 10, 2022. Results: Random network meta-analysis was conducted to estimate the differences between different protocols of IPL treatment in ocular surface disease index (OSDI), standard patient evaluation of eye dryness (SPEED), tear break-up time (TBUT), meibomian gland quality (MGQ), meibomian gland evaluation (MGE), and corneal fluorescein staining (CFS). Rank probability showed OPT-based IPL plus MGX ranked first in OSDI and SPEED, E &gt; eye-based IPL plus MGX ranked first in TUBT, MGQ, and CFS, but Eyesis-based IPL plus MGX ranked first in MGE. Conclusions: Based on available evidence, for individuals with MGD-related DED, OPT-based IPL plus MGX may be the preferred treatment protocol for relieving ocular symptoms, but E &gt; eye-based IPL plus MGX may be more beneficial for improving ocular function.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Network meta-analysis of different modalities of intense pulsed light therapy in the treatment of dry eye disease induced by meibomian gland dysfunction

  • 期刊论文

  • 发表日期：

    2025年6月26日

查看全文
  • Jing Cong,
  • Yiting Wu,
  • Chunqiong Dong,
  • Yiwen Cheng,
  • Xueqi Lin,
  • Jiayue Yuan,
  • Qianhong Feng,
  • Shichu Liu,
  • Jinhui Dai,
  • Xiaoping Ma,
  • Xinyi Xie

摘要

Purpose: This network meta-analysis aimed to evaluate the comparative effect of five different protocols of IPL treatment in treating MGD-related DED, including optimal pulse technology [OPT]-based IPL, E > eye-based IPL, OPT-based IPL plus meibomian gland expression (MGX), E > eye-based IPL plus MGX, Eyesis-based IPL plus MGX. Methods: PubMed, Embase, Cochrane Library, SCOPUS and China National Knowledge Infrastructure (CNKI) were searched for eligible studies published before November 10, 2022. Results: Random network meta-analysis was conducted to estimate the differences between different protocols of IPL treatment in ocular surface disease index (OSDI), standard patient evaluation of eye dryness (SPEED), tear break-up time (TBUT), meibomian gland quality (MGQ), meibomian gland evaluation (MGE), and corneal fluorescein staining (CFS). Rank probability showed OPT-based IPL plus MGX ranked first in OSDI and SPEED, E > eye-based IPL plus MGX ranked first in TUBT, MGQ, and CFS, but Eyesis-based IPL plus MGX ranked first in MGE. Conclusions: Based on available evidence, for individuals with MGD-related DED, OPT-based IPL plus MGX may be the preferred treatment protocol for relieving ocular symptoms, but E > eye-based IPL plus MGX may be more beneficial for improving ocular function.